Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 59 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Papaefthymiou, Apostolis  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., & Kountouras J. (2020).  Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma.. Aliment Pharmacol Ther. 51(11), 1215-1216.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., Liatsos C., Koffas A., et al. (2020).  Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease.. Aliment Pharmacol Ther. 51(2), 313-314.
I
Kountouras, J., Kazakos E., Kyrailidi F., Polyzos S. A., Zavos C., Arapoglou S., et al. (2023).  Innate immunity and nonalcoholic fatty liver disease.. Ann Gastroenterol. 36(3), 244-256.
Kountouras, J., Papaefthymiou A., Doulberis M., & Polyzos S. A. (2019).  Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk.. Liver Int.
Papaefthymiou, A., Potamianos S., Goulas A., Doulberis M., Kountouras J., & Polyzos S. A. (2021).  Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.. J Crohns Colitis.
Katsinelos, P., Lazaraki G., Anastasiadis S., Chatzimavroudis G., Katsinelos T., Terzoudis S., et al. (2019).  The impact of selective serotonin receptor inhibitors on post-endoscopic sphincterotomy bleeding, alone or with concurrent aspirin or nonsteroidal anti-inflammatory drugs.. Ann Gastroenterol. 32(6), 614-619.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Boziki M., Kyriakopoulos A., et al. (2021).  Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.. J Neurogastroenterol Motil. 27(4), 653-654.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Deretzi G., Vardaka E., Soteriades E. S., et al. (2021).  Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension.. Microorganisms. 9(11), 
Papaefthymiou, A., Doulberis M., Kountouras J., Kolokytha C., Galanopoulos M., Liatsos C., et al. (2019).  Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey.. Eur J Gastroenterol Hepatol.
Ntona, S., Papaefthymiou A., Kountouras J., Gialamprinou D., Kotronis G., Boziki M., et al. (2023).  Impact of nonalcoholic fatty liver disease-related metabolic state on depression.. Neurochem Int. 163, 105484.
Papaefthymiou, A., Doulberis M., Katsinelos P., Liatsos C., Polyzos S. A., Kotronis G., et al. (2019).  Impact of nitric oxide's bidirectional role on glaucoma: focus on Helicobacter pylori-related nitrosative stress.. Ann N Y Acad Sci.
Kountouras, J., Papaefthymiou A., Doulberis M., Polyzos S. A., Zavos C., Kazakos E., et al. (2021).  Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction.. J Neurogastroenterol Motil. 27(1), 147-148.
Kountouras, J., Doulberis M., Papaefthymiou A., & Polyzos S. A. (2020).  Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation risk.. Liver Int.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Vardaka E., Touloumtzi M., et al. (2022).  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.. Arq Bras Cardiol. 119(3), 502-504.
H
Polyzos, S. A., Papaefthymiou A., Doulberis M., Katsinelos P., & Kountouras J. (2020).  Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited.. J Gastrointestin Liver Dis. 29(2), 270-271.
Doulberis, M., Pierre N. Thierry, Manzini G., Papaefthymiou A., Kountouras J., Klukowska-Rötzler J., et al. (2021).   Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients.. Microorganisms. 9(7), 
Doulberis, M., Papaefthymiou A., Polyzos S. A., Kotronis G., Gialamprinou D., Tzitiridou-Chatzopoulou M., et al. (2020).  Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?. Obes Surg.
Kountouras, J., Papaefthymiou A., Gavalas E., Polyzos S. A., Boziki M., Kyriakou P., et al. (2020).  Helicobacter pylori infection as a potential risk factor for multiple sclerosis.. Med Hypotheses. 143, 110135.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Elisabeth V., et al. (2019).  Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.. Cell Mol Life Sci. 76(13), 2487-2488.
Polyzos, S. A., Papaefthymiou A., Doulberis M., Mavridoglou G., & Kountouras J. (2021).  Helicobacter pylori infection and diabetes mellitus.. Diabetes Metab Syndr. 15(3), 845-846.
G
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
E
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'.. Carcinogenesis.
Kountouras, J., Doulberis M., Polyzos S. A., Kazakos E., Vardaka E., Tzitiridou-Chatzopoulou M., et al. (2022).  Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection.. Intern Med J. 52(9), 1654-1655.
Papaefthymiou, A., Doulberis M., Karafyllidou K., Chatzimichael E., Deretzi G., Exadaktylos A. K., et al. (2021).  Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease.. Minerva Endocrinol (Torino).

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές